Acumen Hypotension Prediction Index (HPI) Feature Software vs Imbio PHA (4.0.0)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Acumen Hypotension Prediction Index (HPI) Feature Software

by Edwards Lifesciences

Imbio PHA (4.0.0)

by Imbio (a subsidiary of 4DMedical)

AI Verdict

Tool A specializes in real-time predictive monitoring of hypotensive events using physiological data for proactive hemodynamic management in acute care settings. In contrast, Tool B focuses on automated cardiac structure measurements from CT pulmonary angiogram scans to aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. While both are categorized under Cardiology AI, their distinct data inputs and clinical applications make them suitable for different aspects of patient assessment and care.

Choose Acumen Hypotension Prediction Index (HPI) Feature Software if…

Choose Acumen HPI if you require real-time, predictive monitoring to proactively manage and prevent hypotensive events in critically ill or surgical patients. This tool is ideal for clinicians needing early alerts and insights into hemodynamic parameters like preload, afterload, and contractility to guide immediate interventions and improve patient outcomes.

View Acumen Hypotension Prediction Index (HPI) Feature Software →

Choose Imbio PHA (4.0.0) if…

Choose Imbio PHA if you need automated, AI-powered analysis of CT pulmonary angiogram (CTPA) scans to quickly assess cardiac structures. This software is best suited for radiologists and cardiologists seeking diagnostic support and risk stratification for conditions like pulmonary embolism and hypertension through objective measurements of ventricular and pulmonary artery dimensions.

View Imbio PHA (4.0.0) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Acumen Hypotension Prediction Index (HPI) Feature Software	Imbio PHA (4.0.0)
Deployment	Unknown	Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel).
FDA Status	Cleared AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Acumen Hypotension Prediction Index (HPI) Feature Software

Tool A, Acumen HPI, integrates directly into the Edwards Lifesciences HemoSphere monitoring platform, providing real-time predictive alerts and a 'Relationship View' screen for immediate insights into hemodynamic parameters. This direct integration and real-time feedback within an existing critical care workflow likely offers a more seamless and immediate user experience for its target clinicians compared to Tool B's image post-processing.

Clinical Value

Acumen Hypotension Prediction Index (HPI) Feature Software

Tool A, Acumen HPI, has demonstrated a significant reduction in the incidence, duration, and severity of intraoperative hypotension, directly impacting patient outcomes by enabling proactive hemodynamic management. While Tool B, Imbio PHA, aids in diagnosis and risk stratification for serious conditions, Tool A's direct impact on preventing adverse events with documented reductions in hypotension duration provides a stronger claim for immediate clinical value.

Pricing & Value

Tie

Both Tool A and Tool B require direct contact with the vendor for pricing information, making a direct comparison of their pricing models impossible. Without transparent pricing, it is not feasible to assess the value proposition of either tool relative to its cost.

Enterprise Readiness

Imbio PHA (4.0.0)

Both tools are FDA-cleared and HIPAA compliant with BAAs, meeting essential regulatory and security standards. However, Tool B, Imbio PHA, offers more flexible deployment options including Cloud, Enterprise (on-premise), or via partners, which caters to a wider range of enterprise IT infrastructures and preferences. Tool A is integrated into a specific platform, which might limit its readiness for environments not already using Edwards Lifesciences HemoSphere.

Innovation

Acumen Hypotension Prediction Index (HPI) Feature Software

Tool A, Acumen HPI, is described as a 'first-of-its-kind technology' that uses machine learning for real-time predictive analysis of blood pressure waveforms to forecast hypotensive events up to 15 minutes in advance. This proactive, real-time predictive capability for a critical physiological event represents a higher degree of innovation in its application compared to Tool B's AI-powered automated image measurement, which, while valuable, is a more established application of AI in healthcare.

Support & Docs

Tie

Both Edwards Lifesciences (Tool A) and Imbio (Tool B) are established companies in the healthcare technology sector and are expected to provide comprehensive customer support and documentation. While web searches confirm the availability of technical support and user manuals for both, the provided information does not offer sufficient detail to distinguish between the quality or extent of their support offerings.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Acumen Hypotension Prediction Index (HPI) Feature Software	Imbio PHA (4.0.0)
Product Name	Acumen Hypotension Prediction Index (HPI) Feature Software	Imbio PHA (4.0.0)
Company	Edwards Lifesciences	Imbio
Primary Function	Predictive monitoring tool that uses machine learning to detect and alert clinicians to the likelihood of a hypotensive event before it occurs.	AI-powered medical image processing software that automatically measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation.
Key AI Application	Machine learning algorithms for predictive analysis of blood pressure waveforms.	Artificial intelligence algorithms for anatomical identification and measurement.
Key Output/Metrics	Hypotension Prediction Index (HPI) parameter (0-100 score), Smart Alerts, Relationship View screen providing insights into preload, afterload, and contractility.	Automated measurement of right and left ventricle diameters, main pulmonary artery and aorta diameters, calculates RV/LV and PA/Ao ratios, generates annotated DICOM images, provides summary reports in PDF format.
Target Medical Area	Hemodynamic management, intraoperative hypotension.	Diagnosis and risk stratification of pulmonary embolism and hypertension.

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index (HPI) Feature Software and Imbio PHA (4.0.0).

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications of the Acumen Hypotension Prediction Index (HPI) Feature Software versus Imbio PHA (4.0.0)?

Acumen HPI is a predictive monitoring tool designed to detect and alert clinicians to the likelihood of a hypotensive event up to 15 minutes before it occurs, aiding in proactive hemodynamic management. Imbio PHA (4.0.0) is an AI-powered medical image processing software that automatically measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension.

What type of patient data or imaging is required for each tool?

The Acumen HPI software uses machine learning algorithms to analyze blood pressure waveforms, compatible with both invasive (arterial line) and non-invasive (Acumen IQ cuff) monitoring. Imbio PHA (4.0.0) requires contrast-enhanced CT pulmonary angiogram (CTPA) scans as input to perform its automated measurements.

What specific metrics or insights do these tools provide to aid in patient management?

Acumen HPI provides an HPI parameter (0-100 score), Smart Alerts and a Smart Trend screen for impending hypotensive events, and a Relationship View screen offering insights into preload, afterload, and contractility. Imbio PHA (4.0.0) provides automated measurements of right and left ventricle diameters, main pulmonary artery and aorta diameters, calculates RV/LV and PA/Ao ratios, and generates annotated DICOM images and summary reports in PDF format.

How do these tools integrate with existing hospital systems or monitoring platforms?

The Acumen HPI Feature Software is integrated into Edwards Lifesciences' HemoSphere advanced monitoring platform. Imbio PHA (4.0.0) can be deployed via Cloud, Enterprise (on-premise), or through partners, and integrates with native DICOM tools and workflows.

Which medical specialties or patient populations are these tools primarily designed to serve?

Acumen HPI is designed for Anesthesiology, Critical Care, and Emergency Medicine, and is intended for use in surgical and non-surgical patients receiving advanced hemodynamic monitoring. Imbio PHA (4.0.0) is intended for Cardiology, Pulmonology, and Radiology specialties, aiding in the assessment of right ventricular enlargement in patients undergoing CTPA.

Does one tool offer predictive capabilities while the other focuses on diagnostic measurements?

Yes, Acumen HPI is a predictive monitoring tool that uses machine learning to predict hypotension up to 15 minutes before an event occurs. In contrast, Imbio PHA (4.0.0) is an image processing software that provides automated measurements of cardiac structures from existing CTPA scans to aid in diagnosis and risk stratification.